Biomerica

BMRA · NASDAQ

$1.72−$0.0413 (−2.35%)TodayMarket closed ·
Prev close $1.76

Latest news

  • Press releaseGlobe Newswire

    Biomerica Reports First Quarter Fiscal 2027 Financial Results

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseGlobe Newswire

    Biomerica Reports Fiscal 2026 Year-End Financial Results

  • NewsCaroline Ryan

    Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy

  • Press releaseGlobe Newswire

    Biomerica Announces $2.23 Million Financing

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseGlobe Newswire

    Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development

  • Press releaseBusiness Wire

    ConsumerDirect Expands Executive Team with Appointment of Gary Lu, CPA as Chief Financial Officer

  • Press releaseGlobe Newswire

    Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

  • Press releaseGlobe Newswire

    Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway

  • Press releaseGlobe Newswire

    Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs

  • Press releaseGlobe Newswire

    Biomerica Reports Third Quarter Fiscal 2026 Financial Results

  • News

    Biomerica Receives First Commercial Order For Hp Detect, Helicobacter Pylori Diagnostic Stool Antigen Test

  • Press releaseGlobe Newswire

    Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

  • Press releaseGlobe Newswire

    Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Moves Higher; Travelers Earnings Beat Estimates

  • NewsAvi Kapoor

    Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings

  • News

    Watching Biomerica; Co Named In 'Research Shows Blood Test May Provide Personalized Dietary Therapy For Patients With Irritable Bowel Syndrome'; Michigan Medicine And Cleveland Clinic Study Finds Blood Test-Guided Diet Reduces Abdominal Pain In IBS Patients

  • News

    Apple, Rivian, Unitedhealth, Biomerica, Tesla: Why These 5 Stocks Are On Investors' Radars Today

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates

  • NewsAvi Kapoor

    Crude Oil Down 1%; Bank of America Posts Upbeat Earnings

  • NewsAvi Kapoor

    US Stocks Edge Lower; Retail Sales Increase Less Than Expected

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.